Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s metadata. No visible changes to study details or navigation are evident.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page version was updated from v3.6.3 to v3.6.4, indicating a minor maintenance update. This change does not alter the study details, data, or user-facing information on the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange Detected- A new bibliographic citation for Exagamglogene Autotemcel with a correction notice was added to Publications. The prior online-ahead-of-print citation was removed, reflecting an updated reference entry.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance update to the page's template or underlying platform. This change does not appear to modify the study data, layout, or visible content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision stamp was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page in the revision history.SummaryDifference0.0%

- Check59 days agoChange DetectedRecruitment status now indicates enrollment closure, and the page revision is updated to v3.6.0. New study-record navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a publication citation were added, while the intervention label formatting appears updated.SummaryDifference0.4%

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.